FDA Inspection 1017569 — Los Angeles General Medical Center
The FDA completed an inspection of Los Angeles General Medical Center on June 15, 2017 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 15, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Los Angeles, CA (United States)